AngioDynamics reports a quarterly results update in which both earnings per share (EPS) and revenue come in above analyst expectations, according to multiple sources. Seeking Alpha states the company posts GAAP EPS of negative $0.07, which it says is higher than the consensus by $0.11, while revenue is reported at $86.61 million, topping estimates by $6.37 million. Investing.com similarly reports an earnings beat, stating the company beats expectations by $0.02 for EPS and that revenue also exceeds forecasts, though it does not provide the same figures in the provided excerpt. Across the sources, the shared point is that AngioDynamics’ reported financial metrics for the quarter—both the earnings measure and total revenue—are above what analysts expected. The reports focus on the magnitude of the beat relative to estimates rather than on detailed drivers of performance, and they do not reference guidance or specific operational developments in the provided text.